The rumoured sale of Bayer’s animal health unit to Elanco has been confirmed as going ahead, with the German company set to make $7.6 billion from the sale. The divestment will make Elanco the ...

Bayer has delayed a planned sale of its animal health unit to private equity interests in order to explore a merger with US firm Elanco, claims Reuters. Citing three separate anonymous sources ...

including from the Australian Pesticides and Veterinary Medicines Authority (APVMA), concluding that glyphosate is not carcinogenic. In the United States, Bayer will continue its multipronged ...

Orion's collaboration partner Bayer submits application in China for third indication of darolutamide ...